Back to the main directory
Press Release
- Ernexa Therapeutics to Present New Data in Oral Presentation at AACR Special Conference in Cancer Research by GlobeNewsWire
- Banzai to Present at the Emerging Growth Conference on Wednesday, September 24, 2025 by GlobeNewsWire
- Safety Shot Announces Strategic Board Refresh to Align with New Corporate Vision by GlobeNewsWire
- Birchtech to Present at WeBull “Small-Cap Insights” Webinar on September 24, 2025 by GlobeNewsWire
- Sulista Exploration Results Confirm a New High-Grade Rare Earth District by GlobeNewsWire
- Mount Logan Capital Inc. Begins Trading on Nasdaq Under “MLCI” by GlobeNewsWire
- GD Culture Highlights Shareholder Value of Pallas Capital Acquisition: 7,500 Bitcoin Equals Approximately $22.37 of BTC Per Share by GlobeNewsWire
- Digital Utilities Ventures Provides Corporate Update by GlobeNewsWire
- Cingulate Secures Exclusive Manufacturing Partnership with Bend Bio Sciences to Support Future Commercialization of Next Generation ADHD Treatment by GlobeNewsWire
- Tulikivi is revising downward and focusing its guidance for 2025: Net sales are expected to be EUR 29 to 33 million and comparable operating profit is expected to be EUR 1 to 2 million by GlobeNewsWire
- Tulikivi Corporation: Decision of the Board on capital repayment by GlobeNewsWire
- Net Asset Value(s) by GlobeNewsWire
- Matthews International’s Engineering Business Hosting Energy Summit in Germany by GlobeNewsWire
- Truly Hard Seltzer and Breakout Reality Star, JaNa Craig, Drop New Limited-Edition Flavor: No Shade, Just Tea by GlobeNewsWire
- Flywire Bolsters Product Suite for U.K. Education Market with Enhancements to Student Financial Software (SFS) and U.S. Loans Solution by GlobeNewsWire
- HUMBL Announces CEO Leadership Transition by GlobeNewsWire
- 24/7 Market News: When it’s too cold outside for the Shorts, Investors can buy a VENU Ticket and warm up at the Firepit by GlobeNewsWire
- 24/7 Market News: Kraig Labs Spider Silk is Sustainable Alternative to Petroleum-Derived Plastics by GlobeNewsWire
- Results from Phase 2 COURAGE Trial Demonstrating Potential to Improve Quality of GLP-1 receptor agonist-induced Weight Loss by Preserving Lean Mass, Presented at EASD by GlobeNewsWire
- Indkaldelse til ordinær generalforsamling 2025 by GlobeNewsWire
- Publication of Prospectus by GlobeNewsWire
- Publication of Prospectus by GlobeNewsWire
- EXL Recognized as a Leader by Everest Group in its Healthcare Data, Analytics and AI Services PEAK Matrix® Assessment 2025 by GlobeNewsWire
- Net Asset Value(s) by GlobeNewsWire
- Herzfeld Credit Income Fund, Inc. Commences Tender Offer for up to 5% of Outstanding Common Shares by GlobeNewsWire